Insuffisance cardiaque
JESFC 2024

Insuffisance cardiaque : pronostic et nouvelles approches thérapeutiques

Publié le jeudi 18 janvier 2024

Modérateur(s) :

Fabien Huet , Lamia Kesri-Tartière

Orateur(s) :

Alexandre Unger , Guillaume Coutance , Thibaud Damy , Charles Fauvel , Julie Dangy , Damien Legallois , Sihame Chahid

Dans la session

Alexandre Unger Incremental prognostic value of late gadolinium enhancement extent, transmurality, and pattern in patients with ischemic cardiomyopathy
Guillaume Coutance Importance of transplant era on post-heart transplant predictive models: A UNOS Cohort Analysis
Thibaud Damy Evaluation of disease progression in patients with ATTR amyloidosis with cardiomyopathy following treatment with patisiran: post-hoc analysis of th...
Charles Fauvel Pulmonary Hypertension due to Left Heart Disease: first validation of the 2022 definitions in a prospective study, the PH-HF multicenter study
Julie Dangy Safety and efficacy of heart failure (HF) nurse-led home tele monitoring (HTM) : a single center report
Damien Legallois Identification of anticancer drugs associated with heart failure: a WHO pharmacovigilance database analysis
Sihame Chahid Is heart failure associated with a worse prognosis than cancer? Five year survival following hospitalization with heart failure

Partager l'article :